Literature DB >> 11161934

Coronary artery disease as the cause of incident heart failure in the population.

K F Fox1, M R Cowie, D A Wood, A J Coats, J S Gibbs, S R Underwood, R M Turner, P A Poole-Wilson, S W Davies, G C Sutton.   

Abstract

AIMS: New approaches in the treatment of ischaemic left ventricular dysfunction, including revascularization, make it increasingly important to identify heart failure cases resulting from coronary artery disease. Without angiography these cases may be missed. We investigated the frequency of coronary artery disease in incident cases of heart failure in the population. METHODS AND
RESULTS: We identified all incident cases of heart failure in a population of 292 000 in South London, U.K. by monitoring patients admitted to hospital and through a rapid access heart failure clinic. The presence and severity of coronary artery disease was identified by coronary angiography in patients under 75 years. Myocardial perfusion scanning was used to elucidate the aetiological significance of the coronary artery disease and identify hibernating myocardium. Three hundred and thirty-two cases of new heart failure were identified over 15 months. One hundred and thirty-six cases were under 75 years and angiography was undertaken in 99/136 (73%). Coronary artery disease was the aetiology in 71/136 (52%). In 18 of these 71 cases (25%), the aetiology was not recognised to be due to coronary artery disease prior to angiography, including eight cases with hibernating myocardium.
CONCLUSION: Coronary artery disease is the cause of 52% (95% CI 43-61%) of incident heart failure in the general population under 75 years. Clinical assessment without angiography under-estimates the proportion of patients with coronary artery disease, and fails to identify those patients who may benefit from revascularization. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Year:  2001        PMID: 11161934     DOI: 10.1053/euhj.2000.2289

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  76 in total

Review 1.  Implications of recent heart failure trials for patients with hypertension.

Authors:  P A Poole-Wilson
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

Review 2.  Management of chronic heart failure.

Authors:  Martin R Cowie; Alex Zaphiriou
Journal:  BMJ       Date:  2002-08-24

Review 3.  Preventing clinical heart failure: the rationale and scientific evidence.

Authors:  D A Wood
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 4.  STEMI and heart failure in the elderly: role of adverse remodeling.

Authors:  Anwar Jelani; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

5.  Gene expression profiling in peripheral blood nuclear cells in patients with refractory ischaemic end-stage heart failure.

Authors:  S Szmit; M Jank; H Maciejewski; M Grabowski; R Glowczynska; A Majewska; K J Filipiak; T Motyl; G Opolski
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

6.  Coronary artery disease and outcome in acute congestive heart failure.

Authors:  L Purek; K Laule-Kilian; A Christ; T Klima; M E Pfisterer; A P Perruchoud; C Mueller
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

7.  Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function.

Authors:  M D Thomas; K F Fox; D A Wood; J S R Gibbs; A J S Coats; M Y Henein; P A Poole-Wilson; G C Sutton
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

Review 8.  Mesenchymal stem cells for the treatment of heart failure.

Authors:  Shunsuke Ohnishi; Hajime Ohgushi; Soichiro Kitamura; Noritoshi Nagaya
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

Review 9.  Gender and heart failure: a population perspective.

Authors:  P A Mehta; M R Cowie
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

10.  Therapies for Preventing Heart Failure.

Authors:  Richard F. Wright
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.